1. Home
  2. INSM vs CNH Comparison

INSM vs CNH Comparison

Compare INSM & CNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • CNH
  • Stock Information
  • Founded
  • INSM 1988
  • CNH 1842
  • Country
  • INSM United States
  • CNH United Kingdom
  • Employees
  • INSM N/A
  • CNH N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • CNH Construction/Ag Equipment/Trucks
  • Sector
  • INSM Health Care
  • CNH Industrials
  • Exchange
  • INSM Nasdaq
  • CNH Nasdaq
  • Market Cap
  • INSM 12.6B
  • CNH 12.9B
  • IPO Year
  • INSM 2000
  • CNH N/A
  • Fundamental
  • Price
  • INSM $69.73
  • CNH $12.51
  • Analyst Decision
  • INSM Strong Buy
  • CNH Buy
  • Analyst Count
  • INSM 17
  • CNH 11
  • Target Price
  • INSM $95.93
  • CNH $14.91
  • AVG Volume (30 Days)
  • INSM 2.3M
  • CNH 17.3M
  • Earning Date
  • INSM 05-08-2025
  • CNH 07-30-2025
  • Dividend Yield
  • INSM N/A
  • CNH 2.00%
  • EPS Growth
  • INSM N/A
  • CNH N/A
  • EPS
  • INSM N/A
  • CNH 0.80
  • Revenue
  • INSM $381,030,000.00
  • CNH $18,846,000,000.00
  • Revenue This Year
  • INSM $29.15
  • CNH N/A
  • Revenue Next Year
  • INSM $115.02
  • CNH $5.19
  • P/E Ratio
  • INSM N/A
  • CNH $15.65
  • Revenue Growth
  • INSM 20.77
  • CNH N/A
  • 52 Week Low
  • INSM $53.69
  • CNH $9.28
  • 52 Week High
  • INSM $84.91
  • CNH $13.87
  • Technical
  • Relative Strength Index (RSI)
  • INSM 53.15
  • CNH 46.88
  • Support Level
  • INSM $65.56
  • CNH $12.72
  • Resistance Level
  • INSM $68.74
  • CNH $13.12
  • Average True Range (ATR)
  • INSM 2.41
  • CNH 0.30
  • MACD
  • INSM 0.42
  • CNH -0.11
  • Stochastic Oscillator
  • INSM 76.91
  • CNH 3.77

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.

Share on Social Networks: